BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 24656278)

  • 21. Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.
    Özer İ; Karaçin C; Adışen E; Güz G; Ali Gürer M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27862787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hidradenitis suppurativa: a review with a focus on treatment data.
    Barlev D; Eisen DB; Alikhan A
    Skin Therapy Lett; 2015; 20(4):1-8. PubMed ID: 26382710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous squamous cell carcinoma complicating hidradenitis suppurativa: a review of the prevalence, pathogenesis, and treatment of this dreaded complication.
    Chapman S; Delgadillo D; Barber C; Khachemoune A
    Acta Dermatovenerol Alp Pannonica Adriat; 2018 Mar; 27(1):25-28. PubMed ID: 29589641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful use of brachytherapy for a severe hidradenitis suppurativa variant.
    Paul S; Bach D; LeBoeuf NR; Devlin PM; Lipworth AD
    Dermatol Ther; 2016 Nov; 29(6):455-458. PubMed ID: 27425163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
    Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
    J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hidradenitis suppurativa and perianal Crohn disease: differential diagnosis.
    Bassas-Vila J; González Lama Y
    Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():27-31. PubMed ID: 28081767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of hidradenitis suppurativa with biologic medications.
    Lee RA; Eisen DB
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S82-8. PubMed ID: 26470624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disseminate recurrent folliculitis as the presenting picture of hidradenitis suppurativa.
    Revuz J
    Ann Dermatol Venereol; 2017 Nov; 144(11):715-718. PubMed ID: 28838562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel splice site mutation in NCSTN underlies a Japanese family with hidradenitis suppurativa.
    Nomura Y; Nomura T; Sakai K; Sasaki K; Ohguchi Y; Mizuno O; Hata H; Aoyagi S; Abe R; Itaya Y; Akiyama M; Shimizu H
    Br J Dermatol; 2013 Jan; 168(1):206-9. PubMed ID: 22834455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful control of hidradenitis suppurativa with verapamil: a case report.
    Laroche ML; Teste M; Vanoost J; Geniaux H
    Fundam Clin Pharmacol; 2019 Feb; 33(1):122-124. PubMed ID: 30025186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful surgical treatment for squamous cell carcinoma arising from hidradenitis suppurativa: A case report and literature review.
    Huang C; Lai Z; He M; Zhai B; Zhou L; Long X
    Medicine (Baltimore); 2017 Jan; 96(3):e5857. PubMed ID: 28099342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history, presentation, and diagnosis of hidradenitis suppurativa.
    Micheletti RG
    Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S51-3. PubMed ID: 25188458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New onset of articular inflammatory manifestations in patients with hidradenitis suppurativa under treatment with infliximab.
    Acquacalda E; Roux CH; Albert C; Breuil V; Passeron T; Euller-Ziegler L
    Joint Bone Spine; 2015 Oct; 82(5):362-4. PubMed ID: 25776450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of biological treatments in patients with hidradenitis suppurativa.
    Martin-Ezquerra G; Masferrer E; Masferrer-Niubò M; Ferran M; Sánchez-Regaña M; Collgros H; Bordas X; Notario J; Alsina M; Gil I; Izquierdo N; Aparicio G; Mollet J; Garcia-Patos V; Pujol RM
    J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):56-60. PubMed ID: 24629001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Squamous cell carcinoma of the perineum masquerading as necrotizing hidradenitis suppurativa.
    Harview CL; Truong AK; Worswick SD; Sarantopoulos GP; Hsiao JL
    Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29906008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current and emerging nonsurgical treatment options for hidradenitis suppurativa.
    Kerdel FA
    Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S57-9. PubMed ID: 25188460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient Satisfaction and Quality of Life Following Surgery for Hidradenitis Suppurativa.
    Kohorst JJ; Baum CL; Otley CC; Roenigk RK; Pemberton JH; Dozois EJ; Tran NV; Davis MD
    Dermatol Surg; 2017 Jan; 43(1):125-133. PubMed ID: 28027202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of photodynamic therapy to treat hidradenitis suppurativa a review and critical analysis.
    Scheinfeld N
    Dermatol Online J; 2015 Jan; 21(1):. PubMed ID: 25612117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on Hidradenitis Suppurative (Part II): Treatment.
    Martorell A; García FJ; Jiménez-Gallo D; Pascual JC; Pereyra-Rodríguez J; Salgado L; Villarrasa E
    Actas Dermosifiliogr; 2015 Nov; 106(9):716-24. PubMed ID: 26277040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical hidradenitis suppurativa.
    Naasan H; Affleck A
    Clin Exp Dermatol; 2015 Dec; 40(8):891-3. PubMed ID: 25917371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.